147 related articles for article (PubMed ID: 12930442)
1. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model.
Zellweger T; Kiyama S; Chi K; Miyake H; Adomat H; Skov K; Gleave ME
BJU Int; 2003 Sep; 92(4):463-9. PubMed ID: 12930442
[TBL] [Abstract][Full Text] [Related]
2. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells.
Kyprianou N; King ED; Bradbury D; Rhee JG
Int J Cancer; 1997 Jan; 70(3):341-8. PubMed ID: 9033638
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of cell death in LNCaP cells by overexpression of clusterin].
Xin DQ; Zhu XH; Ai JK; Na YQ; Guo YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):154-8. PubMed ID: 15100733
[TBL] [Abstract][Full Text] [Related]
6. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
Miyake H; Hara I; Gleave ME; Eto H
Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
[TBL] [Abstract][Full Text] [Related]
7. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 Jan; 60(1):170-6. PubMed ID: 10646870
[TBL] [Abstract][Full Text] [Related]
8. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
Muenchen HJ; Poncza PJ; Pienta KJ
Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N; Rock S
Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
12. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.
Scaltriti M; Brausi M; Amorosi A; Caporali A; D'Arca D; Astancolle S; Corti A; Bettuzzi S
Int J Cancer; 2004 Jan; 108(1):23-30. PubMed ID: 14618611
[TBL] [Abstract][Full Text] [Related]
13. Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo.
Hara I; Miyake H; Gleave ME; Kamidono S
Jpn J Cancer Res; 2001 Nov; 92(11):1220-4. PubMed ID: 11714447
[TBL] [Abstract][Full Text] [Related]
14. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
Gleave M; Miyake H
World J Urol; 2005 Feb; 23(1):38-46. PubMed ID: 15770517
[TBL] [Abstract][Full Text] [Related]
15. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy.
July LV; Akbari M; Zellweger T; Jones EC; Goldenberg SL; Gleave ME
Prostate; 2002 Feb; 50(3):179-88. PubMed ID: 11813210
[TBL] [Abstract][Full Text] [Related]
16. Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis.
Scaltriti M; Bettuzzi S; Sharrard RM; Caporali A; Caccamo AE; Maitland NJ
Br J Cancer; 2004 Nov; 91(10):1842-50. PubMed ID: 15494717
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
20. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
